The Cannigma

MARCH 18, 2021

41% said cannabis somewhat addressed motor symptoms (43% for stiffness and 42% for tremors) 43% said cannabis somewhat addressed non-motor symptoms (46% for anxiety, 44% for sleep disorders, 44% for pain). The study was compiled by way of an anonymous email survey sent to 7,607 people with Parkinson’s disease in January 2020.

Patients 138

Patients Clinical Trials Treatment Cannabis 138

The Cannigma

JULY 20, 2021

With this method, you’ll be looking at the most dominant cannabinoids and terpenes in a given cannabis plant, and will choose your cannabis based on their known properties. There are many studies that can speak to these effects, but most of them are pre-clinical, which means they don’t involve human participants. Helping anxiety.

Strains 145

Strains Terpenes Concentrates THC 145

The Cannigma

JUNE 24, 2021

For instance when it comes to pain relief, THC and CBD have shown to be safer than opioids; and for anti-anxiety and sleep aids, CBD does not appear to be habit-forming like benzodiazepines. Getting a good night’s sleep is a crucial step in leading a healthier lifestyle, and the benefits can be felt throughout the day.

CBD 75

CBD Microdosing Edibles Sleep 75

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Healer

MARCH 26, 2021

THC is the main psychoactive compound in marijuana, while CBD is a non-intoxicating cannabinoid found in the cannabis plant. It’s estimated that 2020 spending was about $48 million. . Funding for all research into cannabis also has increased, from $111 million in 2015 to an estimated $196 million in 2020. .

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

JUNE 4, 2021

We support the Hemp Roundtable’s statements on psychoactive hemp and that it should be regulated separately from hemp, CBD, CBG and other non-psychoactive or non-intoxicating cannabinoids. D8 may well assist with relaxation and sleep. They also sleep better and aren’t as bothered by “Musculo-Skeletal Discomfort”.

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

CannaMD

AUGUST 26, 2020

A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD.

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

NOVEMBER 24, 2021

The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC). The Office of Drug Control (ODC) (ODC 2020 ), alongside the Therapeutic Goods Administration (TGA), regulates the production of cannabis and cannabis products.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

DECEMBER 30, 2019

After this historically successful year, we expect to see public and political support continue to increase in 2020 as more and more states implement sensible cannabis regulatory policies. A House floor vote on HR 3884 is anticipated in 2020. FY 2020 Successful House Appropriations Advancements. Erik Altieri.

Legislation 59

Legislation Patients Access Banking 59

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Published in late 2020, Brian has since appeared on dozens of media outlets, including Joe Rogan’s podcast, CNN, and Vice.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

The Cannigma

MARCH 12, 2021

And he’s looking at it and all these words are coming out, cannabinoids, THC, CBD, ratios, terpenes, and the customer realizes they have no idea what they’re doing. They want also maybe CBD and they want terpenes and they want other cannabinoids in there. and those are intertwined in – they do want THC, but not just THC.

Legalization 128

Legalization Patients Education Dispensary 128